Long-term vaginal ring pessary use: discontinuation rates and adverse events.
about
An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapseSelf-management of vaginal pessaries for pelvic organ prolapsePelvic organ prolapse: A primer for urologists.Pessary treatment for pelvic organ prolapse and health-related quality of life: a reviewEffects of pelvic organ prolapse ring pessary therapy on intravaginal microbial flora.A nationwide survey concerning practices in pessary use for pelvic organ prolapse in The Netherlands: identifying needs for further research.Diagnosis and Therapy of Female Pelvic Organ Prolapse. Guideline of the DGGG, SGGG and OEGGG (S2e-Level, AWMF Registry Number 015/006, April 2016).Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.Levator ani muscle avulsion is a risk factor for vaginal pessary expulsion within 1 year for pelvic organ prolapse.Pessary types and discontinuation rates in patients with advanced pelvic organ prolapse.Management of apical compartment prolapse (uterine and vault prolapse): A FIGO Working Group report.The cube pessary: an underestimated treatment option for pelvic organ prolapse? Subjective 1-year outcomes.Primary treatment of pelvic organ prolapse: pessary use versus prolapse surgery.Symptoms, quality of life, and factors affecting women's treatment decisions regarding pelvic organ prolapse.Ureterovaginal fistula linked to a retained pessary.Laparoscopic sacrocolpopexy: an observational study of functional and anatomical outcomes.Pessary use in stress urinary incontinence: a review of advantages, complications, patient satisfaction, and quality of life.Is the menstrual cup harmless? A case report of an unusual cause of renal colic.
P2860
Q26801638-330C14AE-6EC5-44CC-8027-8EC5EE1D591AQ27319504-38C1FCC6-5D5A-4A1D-B0D8-C0CE45D917B6Q33769870-4B9157D0-C8F2-4BA5-8550-CBEB7C896A33Q34990553-03727DDA-92CA-40DA-AA36-59CC015E7D60Q35777826-1316952B-5ED3-4AC4-8AA1-9610E17E3C68Q36073587-B7DB0211-B3FC-4810-ADBD-7B384503D8A7Q37540353-0DF9CEC2-BF3D-4680-AB9C-557988719F1AQ38621074-C52BA84F-DA15-4461-85FD-10DA5C951B54Q39025614-7C825E54-3565-4EC8-9642-165A92D4B7B4Q39036070-843F9EBF-4383-40E5-BC9E-8FEA36C190FFQ40410268-14A4035A-949B-4382-8B80-A91CF6BF6E81Q45106471-FD7116E4-0C08-407E-BF7B-29FBD34F30B8Q48296894-F340063F-5D2A-4E44-9D47-3D29BB509506Q48471453-0BF82C58-C8F5-4951-B0E0-5BDD17A3169AQ48888378-B1A066B8-AFA9-4D0B-B27C-EDF30426A1B9Q51545356-33ABC990-0CAD-497F-AC09-1AB762E4C405Q55014973-BA7E6027-76CC-4592-9BD8-DB2617FEC285Q55133940-7C17CB00-5F45-4615-A36F-58C6EE0D3431
P2860
Long-term vaginal ring pessary use: discontinuation rates and adverse events.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term vaginal ring pessary use: discontinuation rates and adverse events.
@en
Long-term vaginal ring pessary use: discontinuation rates and adverse events.
@nl
type
label
Long-term vaginal ring pessary use: discontinuation rates and adverse events.
@en
Long-term vaginal ring pessary use: discontinuation rates and adverse events.
@nl
prefLabel
Long-term vaginal ring pessary use: discontinuation rates and adverse events.
@en
Long-term vaginal ring pessary use: discontinuation rates and adverse events.
@nl
P2093
P1476
Long-term vaginal ring pessary use: discontinuation rates and adverse events.
@en
P2093
P304
P356
10.1111/J.1471-0528.2009.02380.X
P577
2009-12-01T00:00:00Z